Newer markers in cancer
Carcinoma: cytokeratin
Sarcoma: desmin / vimentin
Malignant polycythemia rubra vera: V617F JAK2 mutation
FLT3 mutation predicts prognosis in AML
Chromosome 13 abnormality will indicate poor response to conventional treatment in multiple myeloma